Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ECS BOTANICS HOLDINGS LTD Board/Management Information 2021

Jul 1, 2021

64818_rns_2021-07-01_5983e6d1-7e91-486b-9498-1c400f5574d7.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

ASX ANNOUNCEMENT

ECS Botanics Holdings Ltd (ASX:ECS)

2 July 2021

==> picture [103 x 105] intentionally omitted <==

ECS appoints four industry leaders to support growth

ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”) advises that it has appointed four cannabis industry executives, into existing and new production and business development roles, to support the company’s growth. ECS Director, Nan-Maree Schoerie said: “We are excited to have attracted such a depth of talent into the ECS medicinal cannabis team. Building bench strength is critical for the success of the organisation. Our ability to attract such talented and experienced individuals is indicative of the growing confidence in ECS’ strategy.”

Nikita Soukhov – Farm Manager (Victoria)

Nikita, one of Australia’s most accomplished agronomists, joined ECS in May. He has a proven track record of success and has overseen commercial greenhouse and outdoor farm production operations in Australia, Israel and Canada. Nikita’s deep knowledge and experience in regenerative farming, cannabis cultivation, and plant genetics positions both ECS and Nikita to achieve their objective to grow high quality cannabis as sustainably as possible.

Angela Macquarie – General Manager Operations

Angela brings more than 30 years of pharmaceutical experience in the United Kingdom and Australia to ECS. Having held executive roles in the pharmaceutical and cannabis industry, Angela brings a wealth of knowledge in GMP manufacturing and compliance and will be responsible for adding value to ECS’ medicinal cannabis products. Her considerable expertise in pharmaceutical GMP will be pivotal in ensuring ECS achieves one of its primary objectives, to build a highly respected medicinal cannabis pharmaceutical company that doctors, and patients trust.

Michael Clark – Head of European Operations

Michael will join ECS in August as Head of European Operations. Michael began his career with global pharmaceutical company GSK, where he rose to senior management levels. Most recently he has led the European Operations of a leading Australian medicinal cannabis, healthcare company and prior to this, he led an EMEA natural healthcare company as their General Manager. Based in Switzerland Michael will leverage his business development

==> picture [596 x 69] intentionally omitted <==

==> picture [43 x 43] intentionally omitted <==

acumen and experience to unlock the significant growth potential in the medicinal cannabis and wellness markets across Europe.

Blaise Bratter – Business Development Manager – Oceania

Since 2018 Blaise has held the role of Global Sales and Operations Manager for an international medicinal cannabis company. Based in Melbourne, Blaise’s network and understanding of the industry’s commercial operations will be invaluable in achieving ECS’s sales objectives across Australia and New Zealand and ensure that customers receive high levels of service and support.

ECS Managing Director Alex Keach said: “ECS has brought together a diversified and bestin-class management team, which has the ability to successfully drive our expansion efforts, progress business development and R&D efforts. The pieces continue to come together to support ECS being a leading cannabis cultivator and manufacturer with considerable pharmaceutical expertise.”

About ECS Botanics Holdings Ltd

ECS Botanics Holdings Ltd is a vertically integrated medicinal cannabis and industrial hemp business. The company owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing, and manufacturing of medicinal cannabis. ECS manufactures to EU GMP standards and also has the necessary licences to cultivate and manufacture medicinal cannabis for the wholesale extract, final dose and premium dry flower market. ECS cultivates hemp for the wholesale market and its retail food and wellness brand, while having obtained all the necessary licences to grow, supply and manufacture. ECS’ core focus is scale and low-cost production, without compromising quality.

For further information, please contact:

Alexander Keach, Managing Director [email protected]

Authorised on behalf of ECS by Alex Keach, Managing Director

==> picture [596 x 67] intentionally omitted <==